Literature DB >> 26307577

Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient Counseling.

Nicole C Schmitt1, Arun Sharma2, Mark R Gilbert3, Seungwon Kim4.   

Abstract

Salivary duct carcinoma (SDC) is a rare salivary malignancy that often presents at advanced stage. Outcomes of low T stage patients with SDC have not been previously examined in detail. We queried our institution's cancer database and identified 28 patients with SDC in situ or T1/T2 SDC. A retrospective chart review was performed, followed by comparison of clinicopathologic features with N stage, disease-free survival, and overall survival. Patients tended to be male, in their sixties, with a high incidence of regional metastases, as in prior reports. Five-year disease-free and overall survival were 49%. Median disease-free survival was 3.24 years, and overall survival was 4.65 years. Parotid location, vascular invasion, facial nerve sacrifice, and extracapsular extension were associated with worse survival. This study provides practical information for counseling of patients who undergo surgery for a parotid mass and are found to have this aggressive malignancy. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  salivary duct carcinoma; salivary malignancy

Mesh:

Year:  2015        PMID: 26307577      PMCID: PMC5022284          DOI: 10.1177/0194599815601659

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  12 in total

1.  Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.

Authors:  Lindsay Williams; Lester D R Thompson; Raja R Seethala; Ilan Weinreb; Adel M Assaad; Madalina Tuluc; Nasir Ud Din; Bibianna Purgina; Chi Lai; Christopher C Griffith; Simion I Chiosea
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

Review 2.  Salivary duct carcinoma: clinical characteristics and treatment strategies.

Authors:  M Guzzo; S Di Palma; C Grandi; R Molinari
Journal:  Head Neck       Date:  1997-03       Impact factor: 3.147

3.  Management and outcome of salivary duct carcinoma in major salivary glands.

Authors:  Elina Salovaara; Olli Hakala; Leif Bäck; Petri Koivunen; Kauko Saarilahti; Fabricio Passador-Santos; Ilmo Leivo; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-22       Impact factor: 2.503

4.  [Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma].

Authors:  O Kleinsasser; H J Klein; G Hübner
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1968

5.  Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.

Authors:  Michael Jaehne; Kerstin Roeser; Thorsten Jaekel; Jan David Schepers; Natalie Albert; Thomas Löning
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

6.  The role of trastuzumab in the management of salivary ductal carcinomas.

Authors:  Anthony J Perissinotti; Matthew Lee Pierce; Makala B Pace; Adel El-Naggar; Merrill S Kies; Michael Kupferman
Journal:  Anticancer Res       Date:  2013-06       Impact factor: 2.480

Review 7.  Salivary duct carcinoma: what is already known, and can we improve survival?

Authors:  D T H Wee; A A Thomas; P J Bradley
Journal:  J Laryngol Otol       Date:  2012-04-12       Impact factor: 1.469

8.  Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.

Authors:  Vijayvel Jayaprakash; Mihai Merzianu; Graham W Warren; Hassan Arshad; Wesley L Hicks; Nestor R Rigual; Maureen A Sullivan; Mukund Seshadri; James R Marshall; David M Cohan; Yujie Zhao; Anurag K Singh
Journal:  Head Neck       Date:  2013-10-07       Impact factor: 3.147

9.  Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.

Authors:  Vishad Nabili; Jesse W Tan; Sunita Bhuta; Joel A Sercarz; Christian S Head
Journal:  Head Neck       Date:  2007-10       Impact factor: 3.147

10.  Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.

Authors:  Michelle D Williams; Dianna Roberts; George R Blumenschein; Stephane Temam; Merrill S Kies; David I Rosenthal; Randal S Weber; Adel K El-Naggar
Journal:  Am J Surg Pathol       Date:  2007-11       Impact factor: 6.394

View more
  6 in total

Review 1.  Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.

Authors:  Nicole C Schmitt; Hyunseok Kang; Arun Sharma
Journal:  Oral Oncol       Date:  2017-09-21       Impact factor: 5.337

2.  VDR in salivary gland homeostasis and cancer.

Authors:  Kara A DeSantis; Samantha L Robilotto; Mark Matson; Noor M Kotb; Cathryn M Lapierre; Zenab Minhas; Alana A Leder; Khushbakht Abdul; Emily M Facteau; JoEllen Welsh
Journal:  J Steroid Biochem Mol Biol       Date:  2020-01-17       Impact factor: 4.292

3.  Treatment outcomes in metastatic and localized high-grade salivary gland cancer: high chance of cure with surgery and post-operative radiation in T1-2 N0 high-grade salivary gland cancer.

Authors:  Jeon Yeob Jang; Nayeon Choi; Young-Hyeh Ko; Man Ki Chung; Young-Ik Son; Chung-Hwan Baek; Kwan-Hyuck Baek; Han-Sin Jeong
Journal:  BMC Cancer       Date:  2018-06-20       Impact factor: 4.430

4.  Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glands.

Authors:  Shayan Cheraghlou; Phoebe K Yu; Michael D Otremba; Saral Mehra; Wendell G Yarbrough; Benjamin L Judson
Journal:  Cancers Head Neck       Date:  2018-07-03

5.  Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma.

Authors:  Sebastian Adeberg; Paul Windisch; Felix Ehret; Melissa Baur; Sati Akbaba; Thomas Held; Denise Bernhardt; Matthias F Haefner; Juergen Krauss; Steffen Kargus; Christian Freudlsperger; Peter Plinkert; Christa Flechtenmacher; Klaus Herfarth; Juergen Debus; Stefan Rieken
Journal:  Front Oncol       Date:  2019-12-20       Impact factor: 6.244

6.  The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan.

Authors:  Kimihide Kusafuka; Yoko Sato; Eiji Nakatani; Satoshi Baba; Matsuyoshi Maeda; Koji Yamanegi; Kaori Ueda; Hiroshi Inagaki; Yoshiro Otsuki; Naoto Kuroda; Kensuke Suzuki; Hiroshi Iwai; Yoshiaki Imamura; Junya Itakura; Shoji Yamanaka; Hideaki Takahashi; Ichiro Ito; Takumi Akashi; Tsutomu Daa; Mei Hamada; Masanori Yasuda; Ryo Kawata; Hidetaka Yamamoto; Yuri Tachibana; Junya Fukuoka; Aya Muramatsu; Kazumori Arai; Makoto Suzuki
Journal:  Head Neck       Date:  2022-03-29       Impact factor: 3.821

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.